[{"Assets_0_Q3_USD":203680028.0,"CommonStockSharesOutstanding_0_Q3_shares":90294937.0,"EarningsPerShareBasic_1_Q3_USD":-0.39,"EarningsPerShareBasic_3_Q3_USD":-0.85,"EarningsPerShareDiluted_1_Q3_USD":-0.4,"EarningsPerShareDiluted_3_Q3_USD":-0.85,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-49260514.0,"NetIncomeLoss_1_Q3_USD":-34134570.0,"NetIncomeLoss_3_Q3_USD":-66699593.0,"StockholdersEquity_0_Q3_USD":162022911.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":87090683.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":79043480.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":86952024.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":78894881.0,"Ticker":"INO","CIK":"1055726","name":"INOVIO PHARMACEUTICALS, INC.","OfficialName":"Inovio Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"674206680.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20171108"}]